Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 16Precursor Cell Lymphoblastic Leukemia-Lymphoma 14Leukemia, Myeloid, Acute 14Hodgkin Disease 13Multiple Myeloma 11Lymphoma, Mantle-Cell 11Myelodysplastic Syndromes 10Lymphoma, Non-Hodgkin 10Lymphoma, Large B-Cell, Diffuse 10Leukemia, Prolymphocytic 9Waldenstrom Macroglobulinemia 8Myeloproliferative Disorders 8Leukemia, Myeloid, Chronic-Phase 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Myelodysplastic-Myeloproliferative Diseases 7Lymphoma, Follicular 6Lymphoma, B-Cell, Marginal Zone 6Leukemia, Myelomonocytic, Chronic 6Burkitt Lymphoma 6Lymphoma 5Primary Myelofibrosis 4Lymphoma, Large-Cell, Immunoblastic 4Leukemia, Prolymphocytic, T-Cell 4Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 4Leukemia 4Hematologic Neoplasms 4Graft vs Host Disease 4Blast Crisis 4Anemia, Refractory, with Excess of Blasts 4Sezary Syndrome 3

Interventions

fludarabine phosphate 10Cyclophosphamide 8Busulfan 8Whole-Body Irradiation 7Peripheral Blood Stem Cell Transplantation 7Mycophenolic Acid 7Antilymphocyte Serum 7Tacrolimus 6Methotrexate 5Cyclosporine 5thymoglobulin 4Melphalan 4Rituximab 3Radiotherapy 3Etoposide 3Cord Blood Stem Cell Transplantation 3Sirolimus 2Ondansetron 2Granulocyte Colony-Stimulating Factor 2Dexamethasone 2Cytarabine 2Carmustine 2Calcium Dobesilate 2Aprepitant 2ruxolitinib 1fludarabine 1fedratinib 1etoposide phosphate 1dexamethasone acetate 1dexamethasone 21-phosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Leukemia, Neutrophilic, Chronic × Cyclosporins × Clear all
NCT00755040 2017-03-07

Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder

Vanderbilt-Ingram Cancer Center

Phase 3 Completed
164 enrolled 8 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Pdgfra-Associated Chronic Eosinophilic Leukemia, Congenital Abnormalities, Blast Crisis, Burkitt Lymphoma, Graft vs Host Disease, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Neutrophilic, Chronic, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡